ON 101

Drug Profile

ON 101

Alternative Names: DCB WH1; ON101; WH 1

Latest Information Update: 03 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Development Center for Biotechnology
  • Developer Oneness Biotech
  • Class Flavanones; Herbal medicines; Terpenes
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Diabetic foot ulcer

Most Recent Events

  • 25 Jan 2017 Phase III clinical trials in Diabetic foot ulcer in Taiwan is underway (NCT01898923)
  • 01 Jul 2015 Oneness Biotech initiates a phase-I clinical trial in Diabetic foot ulcer in Taiwan (Topical) (NCT02353273)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top